Yoshihiro Ujihara1, Keiichiro Iwasaki2, Satomi Takatsu2, Ken Hashimoto3, Keiji Naruse2, Satoshi Mohri1, Yuki Katanosaka4. 1. Department of Cardiovascular Physiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan Department of Physiology, Kawasaki Medical School, Kurashiki, Japan. 2. Department of Cardiovascular Physiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan. 3. Department of Physiology, Kawasaki Medical School, Kurashiki, Japan. 4. Department of Cardiovascular Physiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan ytanigu@md.okayama-u.ac.jp.
Abstract
AIMS: Although increased Na(+)/Ca(2+) exchanger 1 (NCX1) expression is observed during heart failure (HF), the pathological role of NCX1 during the progression of HF remains unclear. We examined alterations of NCX1 expression and activity in hearts after transverse aortic constriction (TAC) surgery and explored whether NCX1 influences pressure overload-induced pathological cardiac remodelling. METHODS AND RESULTS: We generated novel transgenic mice in which NCX1 expression is controlled by a cardiac-specific, doxycycline (DOX)-dependent promoter. In the absence of DOX, TAC surgery caused substantial chamber dilation with a gradual decrease in contractility by 16 weeks. Cardiomyocytes showed a decline in contractility with abnormal Ca(2+) handling during excitation-contraction (E-C) coupling. Reduced NCX1 activity was observed 8 weeks after TAC and was still apparent at 17 weeks. Induced NCX1 overexpression by DOX treatment starting 8 weeks after TAC returned NCX1 activity to pre-TAC levels and prevented chamber dilation with cardiac dysfunction. DOX treatment not only upregulated NCX1 expression in TAC-operated hearts but also returned L-type Ca(2+) channel and sarcoplasmic reticulum (SR) Ca(2+) ATPase expression levels to those in sham-operated hearts. In DOX-treated myocytes, contractility, T-tubule integrity, synchrony of Ca(2+) release from the SR, and Ca(2+) handling during E-C coupling was preserved 16 weeks after TAC surgery. In addition, DOX treatment attenuated the down-regulation of survival signalling and up-regulation of apoptosis signalling 16 weeks after TAC surgery. CONCLUSION: Induced overexpression of NCX1 attenuated pressure overload-induced pathological cardiac remodelling. Thus, maintaining NCX1 activity may be a potential therapeutic strategy for preventing the progression of HF. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Although increased Na(+)/Ca(2+) exchanger 1 (NCX1) expression is observed during heart failure (HF), the pathological role of NCX1 during the progression of HF remains unclear. We examined alterations of NCX1 expression and activity in hearts after transverse aortic constriction (TAC) surgery and explored whether NCX1 influences pressure overload-induced pathological cardiac remodelling. METHODS AND RESULTS: We generated novel transgenic mice in which NCX1 expression is controlled by a cardiac-specific, doxycycline (DOX)-dependent promoter. In the absence of DOX, TAC surgery caused substantial chamber dilation with a gradual decrease in contractility by 16 weeks. Cardiomyocytes showed a decline in contractility with abnormal Ca(2+) handling during excitation-contraction (E-C) coupling. Reduced NCX1 activity was observed 8 weeks after TAC and was still apparent at 17 weeks. Induced NCX1 overexpression by DOX treatment starting 8 weeks after TAC returned NCX1 activity to pre-TAC levels and prevented chamber dilation with cardiac dysfunction. DOX treatment not only upregulated NCX1 expression in TAC-operated hearts but also returned L-type Ca(2+) channel and sarcoplasmic reticulum (SR) Ca(2+) ATPase expression levels to those in sham-operated hearts. In DOX-treated myocytes, contractility, T-tubule integrity, synchrony of Ca(2+) release from the SR, and Ca(2+) handling during E-C coupling was preserved 16 weeks after TAC surgery. In addition, DOX treatment attenuated the down-regulation of survival signalling and up-regulation of apoptosis signalling 16 weeks after TAC surgery. CONCLUSION: Induced overexpression of NCX1 attenuated pressure overload-induced pathological cardiac remodelling. Thus, maintaining NCX1 activity may be a potential therapeutic strategy for preventing the progression of HF. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Nesrine Ebrahim; Hajir A Al Saihati; Ola Mostafa; Amira Hassouna; Sameh Abdulsamea; Eman Abd El Aziz M El Gebaly; Nashwa Hassan Abo-Rayah; Dina Sabry; Mohamed El-Sherbiny; Abdelmonem G Madboly; Noha Ibrahim Hussien; Raja El Hasnaoui Saadani; Hasnaa Ali Ebrahim; Omnia A M Badr; Nehal M Elsherbiny; Rabab F Salim Journal: Int J Mol Sci Date: 2022-05-25 Impact factor: 6.208
Authors: Anna Garcia-Elias; Marta Tajes; Laia Yañez-Bisbe; Cristina Enjuanes; Josep Comín-Colet; Selma A Serra; José M Fernández-Fernández; Kathryn W Aguilar-Agon; Svetlana Reilly; Julio Martí-Almor; Begoña Benito Journal: Int J Mol Sci Date: 2021-09-26 Impact factor: 5.923